the clinical utilization of circulating cell free dna (ccfdna) in blood of cancer patients
Clicks: 177
ID: 157579
2013
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
2.7
/100
9 views
9 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the management of malignant and benign neoplasms. Detecting circulating DNA in cancer patients may help develop a DNA profile for early stage diagnosis in malignancies. The technical issues of obtaining, using, and analyzing CCFDNA from blood will be discussed.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (53 words).
Try re-searching for a better abstract.
| Reference Key |
wu2013internationalthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Yanyuan Wu;Yahya I. Elshimali;Husseina Khaddour;Marianna Sarkissyan;Jaydutt V. Vadgama |
| Journal | Intertax |
| Year | 2013 |
| DOI |
10.3390/ijms140918925
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.